RussianPatents.com

Histo-equivalent bioplastic material. RU patent 2513838.

Histo-equivalent bioplastic material. RU patent 2513838.
IPC classes for russian patent Histo-equivalent bioplastic material. RU patent 2513838. (RU 2513838):

A61L27/44 - having a macromolecular matrix
A61L27/20 - Polysaccharides
A61K38/00 - Medicinal preparations containing peptides (peptides containing beta-lactam rings A61K0031000000; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, A61K0031000000; ergoline-based peptides A61K0031480000; containing macromolecular compounds having statistically distributed amino acid units A61K0031740000; medicinal preparations containing antigens or antibodies A61K0039000000; medicinal preparations characterised by the non-active ingredients, e.g. peptides as drug carriers, A61K0047000000)
Another patents in same IPC classes:
Method for making bioresorbed small-diameter hybrid vascular graft / 2504406
Invention refers to medicine and tissue engineering, and may be used in cardiovascular surgery for small-vessel bypasses. A vascular graft is made by two-phase electrospinning with the staged introduction of the ingredients into the polymer composition.
Micro-nanostructured bioplastic material Micro-nanostructured bioplastic material / 2481127
Invention refers to medicine, namely combustiology, plastic surgery, cosmetology, and can find application as a bioplastic material for skin defect replacement and regeneration stimulation. What is described is a micro-nanostructured bioplastic material which is based on a nanostructured matrix formed of hyaluronic acid; it contains proteoglycans, glycoproteins, fibrous proteins and antiseptic in the following ratio (per 100 ml): hyaluronic acid - 30-20; proteoglycans - 20-30; glycoproteins -10-15, fibrous proteins - 10-15, antiseptic - 5-10; solvent (water) - the rest.
Polymer composite / 2477627
Invention refers to polymer composites with the special characteristics used as medical implants, transformed structures, thermal activators and the other commercial structures. The composite comprises a polymer matrix with working temperatures exceeding fibre configuration recovery temperature, and tensile extension min. 2%, reinforced with the elements presented in the form of fibres extended in one or more directions with the fibre length min. 3 times more than the in-between distance, made of a thermal shape memory alloy.
Organ-specific regenerant gi Organ-specific regenerant gi / 2462255
Invention refers to medicine, namely transplantology, traumatology, general surgery, dentistry, combustiology, plastic surgery, cosmetology. The organ-specific regenerant GI contains a fibrin matrix with thrombin, cryoprecipitate prepared of quarantine fresh-frozen donor plasma. The fibrin matrix is nanostructured and contains thrombolysate enriched by growth factors and cytokines. Cryoprecipitate, thrombolysate and human thrombin in the regenerate are found in equal proportions in the following quantitative relation of the ingredients, mg: cryoprecipitate - 1; thrombolysate - 1; human thrombin -1 0.9%; normal saline - 2 10%; calcium chloride brine -1.
Bioplastic material Bioplastic material / 2458709
Invention refers to medicine, namely combustiology, plastic surgery, cosmetology, and can find application as a bioplastic material for skin defect replacement and regeneration stimulation. In the bioplastic material containing a matrix base made of a native form of hyaluronic acid, a frame of the bioplastic material is prepared by the layered lyophilisation of the matrix material to form a space 0.5 to 10 cm thick with fibres of the native form of hyaluronic acid being directed in the porous order and their cells being enriched with thrombocytic lysate with thrombocyte count 1×109 thromb/ml.
Method of hernioplasty / 2456942
Invention relates to medicine, namely to surgery and can be used in hernioplasty. For this purpose 40-130 ml of autoblood are sampled during operation, centrifuged for 15-20 minutes, erythrocyte layer is removed. 10% solution of calcium chloride is added to remaining leukocyte-platelet layer of centrifugate and blood plasma. Mixture is shaken up. Mesh allomaterial, prepared by the size of operation wound, is soaked with mixture and sewn in the area of hernial ring. Operation wound is sewn tightly.
Fibre-reinforced composite materials and method of obtaining them Fibre-reinforced composite materials and method of obtaining them / 2449772
Group of inventions relates to fibre-reinforced composite materials, in particular to oriented in application composite materials, used in dental and medical fields/devices. Solidified fibre-reinforced composite material includes compounded with each other: system of monomers, containing, at least, one solidified monomer, system of filling agents and initiator(s) of polymerisation, and/or polymerisation accelerator(s). System of filling agents contains, at least, one prepreg, containing 0.5-100 mm long fibres, and polymer matrix, and optionally, at least, one powder filling agent, prepreg being located in form of parts, which are 0.5-100 mm long. As fibre, preferably fibre glass is used. Powder filler is selected from common powder filling agents and nanomeric powder filling agents. Claimed is method of said material obtaining and its application in dental and medical field and corresponding devices, in particular, for filling in dental cavities, as filling composites, temporary and semi-permanent composite material for crowns and bridges, filling and binding materials.
Biological patch and method of its production Biological patch and method of its production / 2438714
Invention relates to medicine. Described is patch for application in surgery, produced by method, which includes stages of selection of animals tissue, which contains substrate, diametrical linking and fixation of substrate, minimisation of substrate agents activity, substrate tanning and binding of active layer to substrate.
Biological wound covering and method of its production Biological wound covering and method of its production / 2438713
Invention relates to medicine. Described is biological wound covering, produced by method, which includes stages of selection of animal tissue, which contains substrate, of diametrical linking and fixation of substrate, minimisation of substrate agents activity and binding of active layer to substrate.
Artificial biological implant for nerve guide membrane and method of its manufacturing Artificial biological implant for nerve guide membrane and method of its manufacturing / 2432968
Invention relates to medicine. Described is artificial biological implant for nerve guide membrane, made by method, which contains stages of selection of connective membrane of animal, transverse sewing and fixation of membrane, minimisation of activity of membrane antigens, tanning of membrane, connection of active layer to internal surface of membrane, cutting membrane to required shape and size, placement of cut membrane on rod-shaped matrix in such a way that cut membrane took cylindrical shape, and attachment of spiral braid (2) to external surface of membrane.
Hyaluronic acid gels containing analgesic agents Hyaluronic acid gels containing analgesic agents / 2496474
Invention refers to medicine. There are described soft tissue fillers, such as cutaneous and subcutaneous fillers based on hyaluronic acids and pharmaceutically acceptable salts thereof. What is described is a hyaluronic acid composition which contains a therapeutically effective amount of at least one analgesic agent, e.g., lidocaine, and additionally non-cross-linked hyaluronic acid. There are also described the methods for preparing the hyaluronic acid compositions.
Biocompatible bone-substituting material and method of obtaining thereof / 2494721
Invention relates to medicine, namely to method of obtaining biocompatible bone-substituting material; powder of biological hydroxyapatite with particle size not more than 40 mcm is obtained from cattle bones, powder of hydroxyapatite is mixed with magnesium phosphate powder with particle size not more than 40 mcm with their ratio 1.0:0.25, water suspension of 2-amino-5-guanidine valeric acid is added to obtained mixture of powders with their further mixing for 40-50 minutes and drying at 50-60°C. Obtained mixture is combined with liquid, containing chitosane solution in 3% water solution of succinic acid and 2% water solution of sodium alginate with their ratio 0.3:0.7, ratio between liquid and powder mixture being 1.0:0.5. Before application hardening agent 5-10% water solution of calcium chloride is added to obtained plastic mass with ratio 1.0:0.3.
Artificial dura mater and method of its production Artificial dura mater and method of its production / 2491961
Invention relates to chemical-pharmaceutical industry and represents artificial dura mater, produced from electrospinning layers by technology of electorspinning, with electrospinning layer, consisting of, at least, hydrophobic electrospining layer, which is produced from one or several hydrophobic polymers, selected from polylatic acid and polycaprolactone.
Micro-nanostructured bioplastic material Micro-nanostructured bioplastic material / 2481127
Invention refers to medicine, namely combustiology, plastic surgery, cosmetology, and can find application as a bioplastic material for skin defect replacement and regeneration stimulation. What is described is a micro-nanostructured bioplastic material which is based on a nanostructured matrix formed of hyaluronic acid; it contains proteoglycans, glycoproteins, fibrous proteins and antiseptic in the following ratio (per 100 ml): hyaluronic acid - 30-20; proteoglycans - 20-30; glycoproteins -10-15, fibrous proteins - 10-15, antiseptic - 5-10; solvent (water) - the rest.
Medical implant and method of its manufacturing Medical implant and method of its manufacturing / 2476187
Invention relates to medicine and pharmaceutical industry, in particular to method of manufacturing elongated hollow body (1). Body, containing crystalline cellulose, has multiple projections (3, 4), which project into lumen of hollow body (1), on internal wall. Method of manufacturing elongated hollow body (1), includes stages: manufacturing hollow form (12), cultivation of cellulose-forming organisms in internal space, formed by hollow form (12), aimed at providing growth of hollow body (1) in internal space; operation of removal of hollow body from form (12). At the stage of removal from form (12), at least, part of hollow form (12) is irreversibly deformed.
Method for preparing biocompatible nanostructure conducting composite / 2473368
Invention refers to a method for preparing a biocompatible nanostructured conducting composite. The method involves preparing an ultra-disperse suspension of carboxymethyl cellulose and carbon nanotubes with the mechanical system of carbon nanotube structuring wherein nanostructuring is enabled by exposing the suspension to laser light in a continuous mode at generation wave lengths 0.81÷0.97 mcm and light intensity 0.5÷5 Wt/cm2.
Bioplastic material Bioplastic material / 2458709
Invention refers to medicine, namely combustiology, plastic surgery, cosmetology, and can find application as a bioplastic material for skin defect replacement and regeneration stimulation. In the bioplastic material containing a matrix base made of a native form of hyaluronic acid, a frame of the bioplastic material is prepared by the layered lyophilisation of the matrix material to form a space 0.5 to 10 cm thick with fibres of the native form of hyaluronic acid being directed in the porous order and their cells being enriched with thrombocytic lysate with thrombocyte count 1×109 thromb/ml.
Bone prosthesis material and method for preparing it Bone prosthesis material and method for preparing it / 2457000
Invention refers to medicine. What is described in a method for preparing a bone prosthesis material which involves producing precursor particles of tricalcium phosphate (TCP) particles; pre-caking the TCP-particles at temperature within the first temperature range to produce the TCP-particles of the diameter within the preset diameter range range; granulating the TCP-particles and caking the granulated bodies at temperature within the second temperature range. The second temperature range includes temperatures exceeding those of the first temperature range. A first gap 100 to 400 mcm is formed in the bone prosthesis material between two caked particle group neighbours. Each caked particle group contains the tricalcium phosphate (TCP) particles which are caked to form a second gap 5 to 100 mcm between two TCP neighbours. The first gap and the second gap are connected. Each caked particle group has a connection portion connecting the TCP-particle, and said connection portion is 5 to 20 mcm wide.
In-situ system for intra-articular regeneration of cartilaginous and bone tissues In-situ system for intra-articular regeneration of cartilaginous and bone tissues / 2451527
Invention refers to medicine. What is described is an implanted multilayer chondral reparation flap showing biological compatibility and physiological resorption, and what is also described is a method providing surgical management in situ for intra-articular regeneration of cartilaginous tissue in joint damages and/or defects. The chondral reparation flap comprises a first external cell-impermeable layer and a second external cell-permeable layer adapted for placement in an immediate proximity from a subchondral bone on a wound portion, and also a cartilage-forming matrix located between the first and second layers. The cartilage-forming matrix represents an accepting medium for diffusion of autologous stem cells and contains chemical components promoting formation of a hyaline-like cartilage in the presence of said autologous stem cells. The method prevents a fibrous cartilaginous replacement tissue from forming within the injury region.
Gel of hyaluronic acid for intracutaneous injection / 2448740
Invention relates to medicine. Described is implant, which can be injected in subcutaneous or intracutaneous way in form of monophase hydrogel, which contains gel, obtained from cross-linked hyaluronic acid and one of its physiologically acceptable salts.
Chronic wound and/or wound chamber healing technique / 2512681
Invention refers to medicine and may be used for chronic wound and/or wound chamber healing. That is ensured by a multiple coating of a patient's chronic wound and/or wound chamber surface with a composition containing a culture medium conditioned by waste products and growth factors of human mesenchymal stem cells, prepared at the stages of a logarithmic and stationary growth phase of a stable cell culture of mesenchymal stem cells, containing biologically active compounds of low-molecular peptides and cytokines, used for human mesenchymal stem cell culture in vitro.

FIELD: medicine.

SUBSTANCE: what is described is a histo-equivalent bioplastic material comprising a carrier in the form of a matrix that is presented by a native form of hyaluronic acid. The histo-equivalent bioplastic material is prepared by mixing 1.5% hyaluronic acid and 5% peptide complex in the following proportions: 80-90 ml and 10-20 ml, respectively to form a viscous elastic gel that is placed on a mould carrier and exposed to ultraviolet photopolymerisation in a laminar flow hood for 5-7 hours, and then transferred onto a perforation apparatus with the finished material being perforated and notched.

EFFECT: more effective wound healing.

1 tbl, 11 dwg, 1 ex

 

The invention relates to medicine, namely to combustiology, surgery, cosmetology and can be used as bioplastic material for the substitution of the defects integumentary tissues (protection from evaporation and infection), and stimulation of regeneration.

The development and study of new biodegradable plastic and biocompatible materials for effective organ-specific regeneration with high functional and aesthetic result is the actual problem in modern regenerative medicine and Transplantology. Obviously, new materials should meet the compliance requirements of the particular morphology of the recipient tissues and promote their functional recovery (Bioartificial organs, 1999; Biocompatibility, 1999; Sudesh et al., 2000; 2004; Biopolymers for Medicinal and Pharmaceutical Applications, 2005).

Currently actively developing the newest direction of medical bioengineering to create tissue-engineering structures and bioisosteric bodies on the basis of biomaterials with new functional properties, the so-called gesticulant-bioplastic materials (BBB) (Shumakov, 1995; Shumakov et al., 2003; Stilman, 2006). A key feature of these materials is their ability to biodegradation natural metabolic pathways in the body with the inclusion of intermediate and final products in biochemical cycles without their system and local accumulation, such as lactic and glycolic acid included in the Krebs cycle. However, such products must not be toxic, and their concentration in the blood line must not exceed the maximum permissible level (Volova YEAR, 2003).

Physiological metabolizing biomaterials that make up a frame basis tissue-engineered constructs, determines the balance of reparative processes without expressed events inflammatory reactions and prevents the phenomenon of immune rejection, while avoiding the body's response to a foreign body (shyshatskyy that is, 2011).

The development of new gesticulant-bioplastic materials (BM) is based on the study of the kinetics of birthrate and dynamics of its mechanical properties, as well as on assessment of the impact and nature of the regenerative process. The nature and degree of severity of this impact are determined by the totality of physical-chemical properties of the actual material and intensity of the response physiological and biochemical reactions of the recipient organism.

Therefore, development of new biodegradable materials with the maximum degree of biochemical complementarity is based on creating a matrix consisting of macromolecular complexes available for private enzyme systems of the body and other lytic agents.

Therefore perfect biodegradable material must meet the following requirements.

1. Macromolecular design with the programmed period biodegradation natural metabolic pathways, which is not the object of immuno-inflammatory reactions.

2. The inclusion of intermediate and/or final products of biomateriali material in regeneration mechanisms on the phase of the signal chemotaxis protective cells.

3. Maximum compliance with the time period biodegradation of material and duration of the reparative process.

Thus, from the perspective of optimal immune-biochemical of compliance the implementation of the above requirements for the development of new biodegradable materials ensure optimum morphological and functional result organ-specific histogenesis.

Early research on the development of biodegradable materials were focused on natural polymers (collagen, cellulose and others), subsequently - on products of chemical synthesis. Examples of such biodegradable polymers are polianytzia, polyesters, high, poly (methylmethacrylate), polyurethanes. There are several key factors that allow you to control the dissolution of the material: the hydrophilic/hydrophobic, amorphous/crystallinity, molecular weight, presence of heteroatoms (for example, in addition to carbon) (Khlusov I.A., 2007).

Naturally, the most promising are the materials, the splitting of which formed a natural monomers. For example, polylactide, polyglycolides, polyoxyalkylene and their copolymers split accordingly to lactic, glycolic, hydroxybutyric acid, of which the Krebs cycle form water and carbon dioxide, deriving from the body naturally.

The prototype of the present invention is nanostructured bioplastic material (RF Patent№2425694 publ. 10.08.11 year), which includes native form of hyaluronic acid, and based on nanostructured matrix representing nanostructured hyaluronic acid, obtained by photochemical knitting, with a honeycomb structure in the range from 50 to 100 nm.

Such structural organization of macromolecules of hyaluronic acid and collagen gives the biomaterial elasticity, increased adhesion, drainage quality, transparency.

However thus obtained macromolecular structure bioplastic material in the clinical setting is not effective enough.

1. The structure of this material is monophasic, resulting in conditions of wound process it forms a homogeneous floor, becoming, thus, in a dry scab (Rakhmatullin P.P. Bioplastic material on the basis of hyaluronic acid: biophysical aspects of pharmacological properties. // Pharmacy. - 2011. - №4. - P.37-39). Feedback from clinicians, homogeneous dry biological scab requires daily dressings with mandatory hydrate formation, which ultimately leads to the prolongation of terms of healing and cicatricial changes with restriction of functions, for example in the joints.

2. Complex nanostructure organization of biomaterial significantly complicates the process of biomateriali in the wound, i.e. in process of healing it is not absorbed and becomes the reason for the accession of secondary infection, and as a consequence, the complicated course of wound process. Accordingly requires removal of material from the wound with dressings, and as the dry scab firmly spaevaet with subject tissues, this procedure is traumatic to the wound and painful for the patient.

3. Monophasic nanostructured organization of biomaterial is not effectively drainage of purulent and leads to the accumulation of fluid beneath the biomaterial, which is necessary for dressings additional material to punch a scalpel and shape it drainage window (Rakhmatullin P.P., burlutskaya I., Adelshin LR, Burtseva TI The effectiveness of a new method of restoration of the skin defect in a patient with congenital epidermolysis bullosa: clinical observation. // Pediatrics. - 2011. Volume 10, Number 2, - S-192). Such manipulations "disturb" the wound and painful tolerated by the patients, especially children.

Thus, the nanostructuring bioplastic material causes the formation of optimal bioengineering properties (adhesion, transparency), but does not provide favorable wound healing and may cause complications.

Effect : increased efficiency of wound healing.

The problem is solved by the fact that in gesticulant-bioplastic material, including a base in the form of a matrix, as the material which is used native form of hyaluronic acid, according to the invention gesticulant-bioplastic material contains 1.5% solution of hyaluronic acid 5% solution peptide complex, mixed before the formation of viscous elastic gel placed the basis and subjected to ultraviolet photopolymerization in laminar cabinets for 5-7 hours at the following quantitative ratio, ml:

- 1.5% solution of hyaluronic acid - 80-90;

- 5% solution of peptide complex - 10-20,

while the team has perforation and notches.

Figure 1 presents microelement gesticulant-bioplastic material, figure 2 - distribution of forces of adhesion to the surface of gesticulant-bioplastic material, figure 3 - relief similarity of biomaterial with skin human figure, figure 4 - the scheme of two-phase structure of biomaterial, located in the wounds, figure 5 - atomic spectrometry image biomaterial after cell cultivation, figure 6 - location scheme of notches and holes gesticulant-bioplastic material on Fig.7 - view trophic ulcers of the left tibia patient diabetes, Fig and 9 - stages bioplastics ulcers left Shin patient diabetes, figure 10 and 11 - the stages of healing of ulcers left Shin patient diabetes.

The structure of the peptide complexes present in the hydrocolloid of hyaluronic acid, is presented in the table, where it is seen that the peptide complexes have different amino acid composition with molecular weight ranging 244-459 Yes. In detected peptides prevail aliphatic (leucine, isoleucine, alanine, glycine) and polar uncharged amino acid residues: threonine, Proline, histidine, serine, and polar charged amino acid residues: arginine, glutamine, asparagine, lysine, arginine. In addition, there are dimer isoleucine and polymer tripeptides, including peptides containing aromatic amino acid residues (tryptophan) and polar uncharged amino acid residues.

The analyzed parameters

Chem. formula

Weight

Delta mass in Nanomolecular mode

Mass in Rel. units

GlyTrpIle

C19H26N4O4

374.19541

-2.33 10.692

IleAspIle

C16H29N3O6

359.20564

12.97 8.674

PheArgPro

C20H30N6O4

418.23285

-0.29 9.024

GlnHisHis

C17H24N8O5

420.18697

-5.74 17.732

AlaTrpLys

C20H29N5O4

403.22195

-5.76 8.934

ProHisTyr

C20H25N5O5

415.18557

-11.10 14.407

ThrTrpTrp

C26H29N5O5

491.21687

-12.84 9.460

LysPheThr

C19H3ON4O5

394.22162

-7.25 8.854

LysArgMet

C17H35N7O4S

433.24712

10.73 9.102

PheCysMet

C17H25N3O4S2

399.12865

4.19 11.108 Ilelle

C12H24N2O3

244.17869

8.67 11.038

AspLysLys

C16H31N5O6

389.22743

16.59 8.863 TrpPro

C16H19N3O3

301.14264

-At 18.38

10.672 GluThr

C9H16N2O6

248.10084

3.47 5.500

Desmosine

C24H4ON5O8

526.28769

-15.37 9.523

It is important that in peptide fractions present desmosine (an amino acid, a derivative of lysine). Due to its complex structure, which has four amino acid group, one molecule of desmosine can be in four peptide chain. Thus it is possible to form two-phase structure of gesticulant-bioplastic material.

In addition, two-phase structure of the new biomaterial due to the difference of forces tension gives the biomaterial unique macroreliefs figure. Metropolitanate gesticulant-bioplastic material biomaterial has a unique relief and looks very similar to dermatoglyphics of human skin.

Due to the different polarities of amino acids is the effect of the surface energy of tension, which affects the formation of the unique mikroelementi.

Atomic spectrometry images ultrastructure surface preparation presents globular formations similar morphology with a unique relief.

It is known that the consolidation of somatic cells is likely to happen on the surface of the material, possessing high surface energy (on a hydrophilic surface), at the same time on basic cellular processes (growth, differentiation, migration) largely influenced by the geometric and dimensional features of the relief of the substrate [Hertz N. Uber die Beruhrung Fester Elastischer Korper (On the contact of elastic solids) // J. Reine Angew. - 2011. - №92. - S. 156 171].

Assessing hydrophilic/hydrophobic properties of the proposed biomaterial method of fixation of the contact angle of the water, the value of which amounted to 83°, calculated on this basis the work of adhesion, which considering the roughness coefficient was equal 99,88 mn/m, which characterizes the surface of the new material as a moderately wet.

Additionally performed visualization of the surface of biopolymer in the registration regime forces of adhesion helped to narrow down the field with high adhesion.

The surface energy of the forces of adhesion is a fundamental characteristic of bioplastic materials for assessment of effective migration of cells on the surface during regeneration. It is established that the presence of local areas with different adhesion ensure taxis cells and uniform their distribution all over the surface (Hallab N.J. Bundy K.J. O'connor, K. et al. Evaluation of metallic and polymeric biomaterial surface energy and surface roughness characteristics for directed cell adhesion // Tissue engineering. - 2001. - V.7. - №1. - P. 55-71).

Estimating on the edge angle of wetting thermodynamic the work of the water on the surface of gesticulant-bioplastic material recorded values of the adhesion forces characterize his two-phase biomaterial with hydrophilic/hydrophobic properties. This is explained by the presence of different substances (amino peptide complex, spatially distributed in the structure of hydrocolloid hyaluronic acid that acts as a basis of the matrix material.

Confirmation of this was a direct visualization of the biomaterial surface mode adhesive-contact atomic force microscopy. The results indicate significant in relation to the visualized area on the biomaterial surface, demonstrating adhesive properties.

In turn, the cultivation of mesenchymal stromal stem cells using gesticulant-bioplastic material as a substrate and subsequent atomic-force microscopy surface has allowed to detect the presence of the cells of the oblong form, of a width 3,7 mm. Further more detailed research revealed that the cell surface is interwoven fibrillar fibers. The similar nature of their arrangement is a sign of that in cultured mesenchymal stem cell migration processes in which they actively interact with the surface of the substrate, penetrating into the subject matrix.

Thus, the presence of peptide complex provides the organization of two-phase structure of the biomaterial which is the basis for the formation of full biological scab in the wound (with the outer surface of the plate, inside - hydrocolloid). Gesticulant-bioplastic material has through the Microperforation for effective drainage of the wound.

Maximum morphological similarity in the structure and appearance of biomaterial with integumentary tissues (skin) gives grounds for introduction in the title of the invention of the term "gesticulant-bioplastic material".

Gesticulant-bioplastic material obtained as follows.

As raw material use hyaluronic acid native form, with fibrous nanostructured structure capable of forming an elastic plate and peptide complex. The native form of hyaluronic acid creates optimal conditions for the migration and proliferation of cells, the source of which are the pieces of viable tissue, placed in the region, however (a kind of cell to cell) gesticulant-bioplastic material.

Prepare a 1.5% solution of hyaluronic acid 5% solution of peptide complex at room temperature. Then they are mixed prior to the formation of viscous elastic gel.

The viscous elastic gel is placed on the form-based and engineered safety Cabinet subjected to ultraviolet photopolymerization.

To do this, in the BSC is created certain microclimate (temperature is 0 to 3 degrees centigrade, humidity - 50-55%, with ventilation air flow rate - 0,50 m/s). Then the mixture is subjected to ultraviolet irradiation for 5-7 hours. The ready material is transferred to the machine for punching and packaging.

In the end, in the forms smooth film whitish color, as similar as possible to the dermatoglyphics picture of human skin.

The plate by cutting given oval shape (large diameter 15 cm, the small diameter - 11 cm)square, oval plate corresponds to the average area of a palm of an adult. In medicine it is believed that the palm of an adult person is about 5% of the body surface, for example, thus, is estimated area of burns.

Then on the plate with the gun applied the round hole, and then mechanically using a special knife. Evenly distributed incisions required for drainage of the wound exudate and more dense connection of biomaterial and the underlying tissue. Round holes with a diameter of 3 mm serve bore holes for epithelial tissues. These fabrics are own tissues of the patient that excising from the edges of the wounds in her surgical treatment. They are used as sources of cells for effective epithelization (healing) of the wound.

As a result of clinical use in patients with defects integumentary tissues found that gesticulant-bioplastic material forms a full biological scab and accelerates wound healing.

It is important to note that gesticulant-bioplastic material was effective in patients who traditional therapy did not help.

Clinical example.

Sick A., 59 years old, lives in Kuvandyk, entered the 4 x/NPH "OKB on Art. Orenburg, JSC "Russian Railways" on 16 December 2011 with a diagnosis of Giant circular purulent-necrotic trophic ulcer of the left tibia. Diabetes type 2 diabetes, severe. Allergic dermatitis lower extremities. Anemia.

Sick for 1 year, how did the plague after suffering necrotic form faces. The size of the defect circular swath width of 8 to 10 cm from n/a 3 to p/3 shank with elements of fascia and ligaments in bottom of the wound. All previously used methods of treatment, including bandages with antiseptics, ointments and a variety of wound coverings effect has not had and extremely painful tolerated by the patient.

Upon receipt of the executed debridement, hewed from necrotic lesions, with getting round pieces of viable tissue of the skin, size 0.5 to 1 mm Then on the prepared wounds impose gesticulant-bioplastic material, having in the structure of Microperforation 3 mm in diameter and notches. After the biomaterial will stick to the wound and become elastic plate in his perforation fit retrieved from saline pieces viable tissues of the patient. Once all of Microperforation will be filled with pieces of cloth, laid sterile napkin and dressing.

Spent a long course of a complex of conservative treatment with correction of comorbidity. We observed formation of two-phase structure of biomaterial, located in the wound: an external plate - biological scab, and internal - hydrocolloid.

After cleansing the wound was formed flat granulating circular defect with edge epithelialization.

When using gesticulant-bioplastic material was established that it has the most powerful stimulating effect on fibroblasts, activating receptors CD44 on the synthesis already own hyaluronic acid, type III collagen and elastin, which prevents the formation of hypertrophic scars.

In the result of the treatment offered by the biomaterial noted that in 2-3 hours after applying all patients reported no pain. Subsequently, it was noted the absence of the phenomenon of the contracture changes wound area and full restoration of the skin. It should be noted that the use of this biomaterial has allowed to avoid inflammatory reaction (abscesses) and formation of hypertrophic scars in the rehabilitation period. Not recorded a single case of allergic and/or inflammatory response in patients.

Thus, in comparison with the prototype conducted investigations show that gesticulant-bioplastic material is able to form a proper biological scab and stimulate healing of wounds with good aesthetic result without scarring, and has high biocompatibility with integumentary tissues the human body.

The novelty is developed gesticulant-bioplastic material is original line-peptide complex, with different amino acids. The availability of this peptide complex provides the organization of two-phase structure of the biomaterial which is the basis for the formation of full biological scab in the wound (with the outer surface of the plate, inside - hydrocolloid). Gesticulant-bioplastic material has through the Microperforation for effective drainage of the wound.

The distinctive feature of this gesticulant-bioplastic material is its ability to form a two-phase wound floor and form so full biological scab, effective drainage of the wound, which ultimately ensures optimal the regeneration of the defect cover tissues without scarring and deformation. In addition, the biomaterial has a special boarding holes for the patient's own tissue, which are formed sprout area for wound healing.

Gesticulant-bioplastic material, including a base in the form of a matrix, as the material which is used native form of hyaluronic acid, wherein specified bioplastic material obtained by mixing of 1.5% solution of hyaluronic acid and 5% solution of peptide complex in the following quantitative ratio: 80 to 90 ml and 10 to 20 ml, accordingly, before the formation of viscous elastic gel, which is placed on the form-based and subjected to ultraviolet photopolymerization in laminar cabinets for 5-7 hours, with the subsequent transfer to the machine for punching, while the ready material has perforation and notches.

 

© 2013-2014 Russian business network RussianPatents.com - Special Russian commercial information project for world wide. Foreign filing in English.